Pharmaceutical - docetaxel

Filter

Current filters:

docetaxel

Popular Filters

UK’s NICE consults on updating guidance for Tarceva and Iressa

UK’s NICE consults on updating guidance for Tarceva and Iressa

04-02-2014

The UK’s National Institute for Health and Care Excellence (NICE) said this morning that it is reviewing…

AstraZenecadocetaxelIressaOncologyPharmaceuticalRegulationRocheTarcevaUK

Australia to review way chemotherapy is funded

07-05-2013

Australia's Minister for Health Tanya Plibersek has announced a major review into the way chemotherapy…

Asia-PacificdocetaxelFinancialGenericsHealthcareOncologyPharmaceutical

India's Cipla cuts prices of three cancer drugs

12-11-2012

Following what Indian drugmaker Cipla (BSE: 500087) said was an "overwhelming response" on the price…

Asia-PacificcapecitabineCipladocetaxelerlotinibGenericsOncologyPatentsPfizerPharmaceuticalPricingSunitinib MalateSutent

Back to top